AMY WULKE: Open Payments
NPI 1770170649 · FLINT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,714 in 43 payments from 15 companies in 2025. Trend: 2023 $2,942 · 2024 $2,569 · 2025 $4,714
Speaker / faculty: $2,700Food & beverage: $1,363Consulting: $560Education: $91
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 12 | $3,625 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $260 |
| Teva Pharmaceuticals USA, Inc. | 4 | $148 |
| E.R. Squibb & Sons, L.L.C. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Indivior Inc. | 4 | $105 |
| Neurocrine BioSciences, Inc. | 4 | $80 |
| ABBVIE INC. | 4 | $68 |
| Braeburn Inc. | 3 | $57 |
| Exact Sciences Corporation | 1 | $23 |
Products named: VIVITROL, CAPLYTA, REXULTI, LYBALVI, COBENFY, SUBLOCADE, INGREZZA, VRAYLAR.
Industry payments across MI — which companies pay providers there.
